Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.
about
A Multilayer Network Approach for Guiding Drug Repositioning in Neglected DiseasesModification of triclosan scaffold in search of improved inhibitors for enoyl-acyl carrier protein (ACP) reductase in Toxoplasma gondii.Drugs in development for toxoplasmosis: advances, challenges, and current status.Enoyl acyl carrier protein reductase inhibitors: an updated patent review (2011 - 2015).
P2860
Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Development of a triclosan sca ...... B-ring for transport peptides.
@en
Development of a triclosan sca ...... B-ring for transport peptides.
@en-gb
Development of a triclosan sca ...... B-ring for transport peptides.
@nl
type
label
Development of a triclosan sca ...... B-ring for transport peptides.
@en
Development of a triclosan sca ...... B-ring for transport peptides.
@en-gb
Development of a triclosan sca ...... B-ring for transport peptides.
@nl
prefLabel
Development of a triclosan sca ...... B-ring for transport peptides.
@en
Development of a triclosan sca ...... B-ring for transport peptides.
@en-gb
Development of a triclosan sca ...... B-ring for transport peptides.
@nl
P2093
P2860
P50
P1476
Development of a triclosan sca ...... B-ring for transport peptides.
@en
P2093
David W Rice
Gustavo A Afanador
Jennifer M Auschwitz
Jozef Stec
Mark R Hickman
Patty J Lee
Rima McLeod
Susan E Leed
P2860
P304
P356
10.1016/J.BMCL.2013.04.035
P407
P577
2013-04-24T00:00:00Z